ZURICH (Reuters) – Lonza Group said on Monday that China’s Junshi Biosciences has licensed the Swiss contract drug manufacturer’s technology to help produce a neutralizing antibody against COVID-19. Lonza said Junshi’s first neutralizing antibody against the n... More »
(Reuters) – Moderna Inc and Swiss contract drugmaker Lonza Group AG said on Friday they would accelerate the manufacturing of the U.S. drug developer’s potential coronavirus vaccine. The announcement comes at a time when drugmakers are pausing clinical trials ... More »
FILE PHOTO – The logo of French drugmaker Sanofi is seen in front of the company’s headquarters in Paris, France, October 30, 2014. REUTERS/Christian Hartmann/File Photo French drugmaker Sanofi and Swiss manufacturer Lonza will invest 270 million euros ($285 m... More »
A logo is pictured on the laboratory building on the Lonza site in Visp, western Switzerland September 10, 2013. REUTERS/Denis Balibouse Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR &... More »
